Loading...

UTHR UNITED THERAPEUTICS CORP Expansion Plans 8-K Filing

NTD

THR

UNITED THERAPEUTICS CORP

(UTHR)

2025 8-K

Show Summary

Summary

Positive Study Results

Financial Statements

Earnings Releases

Debt-Equity Swaps

Earnings Update

Investor Presentation

Earnings Announcement

Earnings Report

Annual Meeting of Shareholders

Earnings Release

Credit Agreement Extension

Share Repurchase Program

Patent Litigation

Earnings and Lawsuit Announ...

Patent Cancellation Decision

License Agreement Extension

Earnings Report

Earnings Release

Amendment and Restatement o...

Earnings Report

Bylaws Amendments

Credit Agreement Extension

Earnings Report

Regulation FD Disclosure

External Links:

On September 2, 2025, United Therapeutics announced positive results from the TETON-2 clinical study of Tyvaso (treprostinil) for idiopathic pulmonary fibrosis. This is deemed a significant event for the company.

AI Assistant

UNITED THERAPEUTICS CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.